Skip to main content
Log in

Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use

  • Letter to the Editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Barbui C, Tansella M, Garattini S (2003) Varying and "atypical" indications for atypical antipsychotics. Psychopharmacology DOI 10.1007/s00213-003-1495-x

  • Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321:1371–1376

    CAS  PubMed  Google Scholar 

  • Sartorius N, Fleischhacker WW, Gjerris A, Kern U, Knapp M, Leonard BE, Lieberman JA, Lopez-Ibor JJ, van Raay B, Twomey E (2002) The usefulness and use of second-generation antipsychotic medications. Curr Opin Psychiatry 15[Suppl 1]:S1–S51

  • Sartorius N, Fleischhacker WW, Gjerris A, Kern U, Knapp M, Leonard BE, Lieberman JA, Lopez-Ibor JJ, van Raay B, Twomey E (2003) The usefulness and use of second-generation antipsychotic medications—an update. Curr Opin Psychiatry 16[Suppl 1]:S1–S44

  • Weiss E, Hummer M, Koller D, Ulmer H, Fleischhacker WW (2000) Off-label use of antipsychotic drugs. J Clin Psychopharmacol 20:695–698

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The European Group for Research in Schizophrenia comprises: Istvan Bitter, Tom Burns, Michael Davidson, W. Wolfgang Fleischhacker, Silvana Galderisi, Jes Gerlach, Rene Kahn, Jan Libiger, Juan Jose Lopez-Ibor, Dieter Naber, Manuel Paes de Sousa, Joseph Peuskens, Wulf Rössler and Goran Sedvall.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to W. Wolfgang Fleischhacker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fleischhacker, W.W., the European Group for Research in Schizophrenia. Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use. Psychopharmacology 169, 207–210 (2003). https://doi.org/10.1007/s00213-003-1496-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1496-9

Keywords

Navigation